Dirk Pleimes

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

Alberto Ascherio, Kassandra L. Munger, Rick White et al. · JAMA Neurology · 2014 · 512 citations

Medicine, Neurology, Pharmacotherapy +17

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

Ludwig Kappos, Gilles Edan, Mark S. Freedman et al. · Neurology · 2016 · 130 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +13

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

Gilles Edan, Ludwig Kappos, Xavier Montalbán et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 82 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

Iris‐Katharina Penner, Brigitte Stemper, Pasquale Calabrese et al. · Multiple Sclerosis Journal · 2012 · 66 citations · Full text

Medicine, Immunology, Neurology +17

Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S.

David W. Kaufman, Shoshana Reshef, Howard L. Golub et al. · Multiple Sclerosis and Related Disorders · 2013 · 50 citations · Full text

Medicine, Neurology, Clinical Epidemiology +7